FIELD: treatment of tumors and transplantation practice. SUBSTANCE: conjugating 14-haloidarubicine (1 da) with monoclonal antibody or fragment thereof containing at least one antigen-binding portion of antigen produces cytotoxic conjugation which is cleaned of darubicine by adsorptive or ion-exchange chromatography. EFFECT: intensified cytotoxic effect of conjugation. 2 tbl
Authors
Dates
1994-03-15—Published
1988-03-10—Filed